Amy D. Dobberfuhl, MD, MS (she/her/hers)

Dr. Amy Dobberfuhl, received a B.S. in Mechanical Engineering from North Carolina State University in 2004 and her M.D. from the University of North Carolina at Chapel Hill School of Medicine in 2010. She completed her residency training in Urology at Albany Medical College in New York in 2015. She then completed an ACGME fellowship in FPMRS (Female Pelvic Medicine & Reconstructive Surgery) with a special emphasis on Neurourology & Voiding Dysfunction, in the Department of Urology at Stanford University in 2017. Dr. Dobberfuhl was also awarded the KL2 component of the Stanford Clinical and Translation Science Award to Spectrum (NIH 5KL2TR001083) and completed an M.S. in Epidemiology and Clinical Research from Stanford University in 2018. Following fellowship in 2017 Dr. Dobberfuhl joined the Department of Urology and her practice includes both a clinical and laboratory research focus.

Dr. Dobberfuhl's clinical practice includes: Pelvic Reconstruction, Neurourology, and Voiding Dysfunction. Dr. Dobberfuhl’s clinical research focus includes: Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS), Nocturia, Urinary tract infection (UTI), Sex differences in lower urinary tract dysfunction, Radiation cystitis, and Overactive (OAB).

Dr. Dobberfuhl’s laboratory basic science and translational research focus includes: IC/BPS, Nocturia, Pelvic floor ischemia, Effect of estrogen on lower urinary tract, Animal models of voiding dysfunction, Urinary biomarkers and molecular mechanisms implicated in lower urinary tract dysfunction (WHSDM LUTS Cohort).

Disclosure information not submitted.

Presentation(s):

• MP49: Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Basic Research & Pathophysiology

  Sunday, May 15, 2022
  4:30 PM – 5:45 PM